Our guest in this episode is Kinneret Shefer, co-founder and CEO of AgTech startup GeneNeer. Kinneret shares the founding of GeneNeer, driven by her shift from pure RNA research to market-driven innovation. GeneNeer aims to revolutionize crop breeding by drastically shortening trait development time using fast, tissue culture-based gene editing platforms. Kinneret compares her vision for GeneNeer to Pfizer's rapid vaccine development during COVID-19, enabling fast responses to agricultural challenges like drought or new pests. GeneNeer's "super line" platform allows rapid, iterative trait development with backup options, while their AI-supported platform enables precise, tissue- and time-specific gene editing without introducing foreign DNA. GeneNeer's business model includes custom collaborations and independent product development.More:GeneNeerKinneret Shefer on LinkedIn

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related